netFormulary Harrogate & Rural District Formulary NHS
Harrogate & District NHS Foundation Trust
Harrogate & Rural District Clinical Commissioning Group
 
 
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Notes:
HDFT Guidelines on the management of stroke

Guidelines for the Management of Hyperglycaemia in Acute Coronary Syndrome (ACS)
Chapter Links...
 Details...
02.12  Expand sub section  Lipid-regulating drugs
02.12  Expand sub section  Statins
Simvastatin
View adult BNF View SPC online View childrens BNF
First Choice
Green
Tablets 20mg, 40mg 
Atorvastatin (Lipitor)
View adult BNF View SPC online View childrens BNF
Second Choice
Green
Tablets 10mg, 20mg, 40mg, 80mg

Initiation by a specialist only.
Atorvastatin 80mg OD for use post ACS for 6 months then switch to simvastatin 40mg if target cholesterol achieved. 
Link  Lipid Modification Guidelines
   
Pravastatin Sodium
View adult BNF View SPC online View childrens BNF
Formulary
Green
Tablets 10mg, 20mg

Use if adverse effects with simvastatin 
   
Rosuvastatin (Crestor)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Green
Tablets 5mg, 10mg, 20mg

For use by Consultant Cardiologists only 
   
02.12  Expand sub section  Bile acid sequestrants
02.12  Expand sub section  Ezetimibe
02.12  Expand sub section  Fibrates to top
02.12  Expand sub section  Nicotinic acid group
02.12  Expand sub section  Omega-3 fatty acid compounds
 ....
 Non Formulary Items
Fluvastatin  (Lescol®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fluvastatin  (Lescol® XL)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Simvastatin and Ezetimibe  (Inegy)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Medicines which are suitable to be prescribed in primary care only after specialist recommendation. Ongoing prescribing by primary care includes titration of dose and assessment of efficacy. There is no need for ongoing monitoring other than for general adverse effects as listed in the BNF & SPC.  

Amber Shared Care

Medicines which are suitable to be prescribed in primary care only after specialist recommendation only under a shared care protocol once the patient has been stabilised. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must be approved by the Harrogate & Rurual District Area Prescribing Committee (HaRD APC).   

Black

Medicines which the Harrogate & Rural District Area Prescribing Committee (HaRD APC) has reviewed and does not recommend for use at present based on a review of clinical and/or cost effectiveness data.   

Green

Medicines suitable for routine use and can be prescribed within primary care within their licensed indication in accordance with nationally recognised formularies e.g. BNF, BNF for Children, Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.  

Grey

Medicines which the Harrogate & Rural District Area Prescribing Committee (HaRD APC) have not yet reviewed.   

Red

Medicines for hospital use only. The responsibility for initiation and monitoring treatment should rest with an appropriate hospital clinician. The drug should be supplied by the hospital for the duration of the treatment course. Primary care prescriber initiation or continuation of treatemnt is not recommended.  

netFormulary